Literature DB >> 31773455

Pain Management in Multiple Sclerosis: a Review of Available Treatment Options.

Talal Aboud1, Nathaniel M Schuster2.   

Abstract

PURPOSE OF REVIEW: Multiple Sclerosis (MS) is a chronic autoimmune disease with no curative treatment available. While recent years have ushered in many effective new disease-modifying therapies for MS, they have not obviated the need for symptomatic treatments for MS-related pain. In this review, we discuss available approaches to control pain, which is one of the most common complaints MS patients have. RECENT
FINDINGS: The most recent research in this topic is directed towards non-pharmacologic interventions including water exercises, yoga and cannabis. More trials are being conducted on neuromodulation for MS-related neuropathic pain, including transcutaneous electrical nerve stimulation (TENS) and transcranial direct current stimulation (tDCS). Pain control for MS patients is challenging, considering the progressive and relapsing remitting nature of the disease, however, it is a very important aspect of it's management, as it improves mobility, exercise tolerance, concomitant depression and overall quality of life. Future research should focus on the use of neuromodulation in controlling MS pain.

Entities:  

Keywords:  Central neuropathic pain; MS disability; MS pain; Multiple sclerosis; Pain; Spasticity

Year:  2019        PMID: 31773455     DOI: 10.1007/s11940-019-0601-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  56 in total

1.  The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis.

Authors:  L Miller; P Mattison; L Paul; L Wood
Journal:  Mult Scler       Date:  2007-01-29       Impact factor: 6.312

2.  Controlled sequential trials of carbamazepine in trigeminal neuralgia.

Authors:  B W Rockliff; E H Davis
Journal:  Arch Neurol       Date:  1966-08

3.  A randomized placebo-controlled trial of duloxetine for central pain in multiple sclerosis.

Authors:  Theodore R Brown; April Slee
Journal:  Int J MS Care       Date:  2015 Mar-Apr

4.  Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis.

Authors:  Orjana Velikonja; Katarina Curić; Ana Ozura; Sasa Sega Jazbec
Journal:  Clin Neurol Neurosurg       Date:  2010-04-04       Impact factor: 1.876

5.  Cervicomedullary junction spinal cord stimulation for head and facial pain.

Authors:  Nestor D Tomycz; Christopher P Deibert; John J Moossy
Journal:  Headache       Date:  2011-01-26       Impact factor: 5.887

6.  Efficacy of Self-Hypnosis in Pain Management in Female Patients with Multiple Sclerosis.

Authors:  Fariba Hosseinzadegan; Moloud Radfar; Ali Reza Shafiee-Kandjani; Naser Sheikh
Journal:  Int J Clin Exp Hypn       Date:  2017 Jan-Mar

7.  Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.

Authors:  Vahid Shaygannejad; Mohsen Janghorbani; Atefeh Vaezi; Sepehr Haghighi; Khodayar Golabchi; Mojtaba Heshmatipour
Journal:  Neurol Res       Date:  2013-04-12       Impact factor: 2.448

8.  A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.

Authors: 
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

9.  Clinical trial of carbazepine (tegretol) in trigeminal neuralgia.

Authors:  F G Campbell; J G Graham; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-06       Impact factor: 10.154

10.  Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions.

Authors:  Cecilie Johannessen Landmark; Pål G Larsson; Elisif Rytter; Svein I Johannessen
Journal:  Epilepsy Res       Date:  2009-08-13       Impact factor: 3.045

View more
  7 in total

1.  [Pain in multiple sclerosis and neuromyelitis optica spectrum disorders].

Authors:  Hannah L Pellkofer; Tania Kümpfel
Journal:  Schmerz       Date:  2021-05-25       Impact factor: 1.107

2.  Pain, quality of life, and religiosity in people with multiple sclerosis.

Authors:  Maddalena Sparaco; Giuseppina Miele; Gianmarco Abbadessa; Domenico Ippolito; Francesca Trojsi; Luigi Lavorgna; Simona Bonavita
Journal:  Neurol Sci       Date:  2021-11-23       Impact factor: 3.830

3.  Behavioral Interventions in Multiple Sclerosis.

Authors:  Aaron P Turner; Lindsey M Knowles
Journal:  Fed Pract       Date:  2020-04

4.  Non-invasive Brain and Spinal Stimulation for Pain and Related Symptoms in Multiple Sclerosis: A Systematic Review.

Authors:  Chiara Zucchella; Elisa Mantovani; Roberto De Icco; Cristina Tassorelli; Giorgio Sandrini; Stefano Tamburin
Journal:  Front Neurosci       Date:  2020-11-20       Impact factor: 4.677

Review 5.  Neuropathic Pain in Multiple Sclerosis and Its Animal Models: Focus on Mechanisms, Knowledge Gaps and Future Directions.

Authors:  Ersilia Mirabelli; Stella Elkabes
Journal:  Front Neurol       Date:  2021-12-16       Impact factor: 4.003

6.  Efficacy of Cannabinoids on Spasticity and Chronic Pain in a Patient with Co-occurrence of Multiple Sclerosis and Neurofibromatosis Type 1.

Authors:  Eleonora Virgilio; Domizia Vecchio; Paola Naldi; Roberto Cantello
Journal:  Eur J Case Rep Intern Med       Date:  2021-05-13

7.  The Crotoxin:SBA-15 Complex Down-Regulates the Incidence and Intensity of Experimental Autoimmune Encephalomyelitis Through Peripheral and Central Actions.

Authors:  Morena Brazil Sant'Anna; Aline C Giardini; Marcio A C Ribeiro; Flavia S R Lopes; Nathalia B Teixeira; Louise F Kimura; Michelle C Bufalo; Orlando G Ribeiro; Andrea Borrego; Wafa H K Cabrera; Julio C B Ferreira; Vanessa O Zambelli; Osvaldo A Sant'Anna; Gisele Picolo
Journal:  Front Immunol       Date:  2020-10-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.